(Q44650585)

5 December 2017

title

Direct 99mTc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and non-invasive imaging studies (English)

1 reference

5 December 2017

Direct 99mTc Labeling of Pegylated Liposomal Doxorubicin (Doxil) for Pharmacokinetic and Non-Invasive Imaging Studies (English)

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

31 March 2024

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

31 March 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

31 March 2024

1 reference

Ande Bao

1

1 reference

5 December 2017

Beth Goins

2

1 reference

5 December 2017

Robert Klipper

3

1 reference

5 December 2017

George Negrete

4

1 reference

5 December 2017

William T. Phillips

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14610219

31 March 2024

language of work or name

English

0 references

publication date

10 November 2003

1 reference

full work available at URL

5 December 2017

https://syndication.highwire.org/content/doi/10.1124/jpet.103.059535

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Journal of Pharmacology and Experimental Therapeutics

31 March 2024

published in

1 reference

5 December 2017

volume

308

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

419-425

1 reference

In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography

5 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Pharmacokinetics of stealth versus conventional liposomes: effect of dose

31 March 2024

2

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours

31 March 2024

3

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

A novel liposome radiolabeling method using 99mTc-"SNS/S" complexes: in vitro and in vivo evaluation

31 March 2024

4

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Separation of large unilamellar liposomes from blood components by a spin column procedure: towards identifying plasma proteins which mediate liposome clearance in vivo

31 March 2024

6

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Whole-animal cellular and molecular imaging to accelerate drug development

31 March 2024

7

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Preparations and properties of tripodal and linear tetradentate N,S-Donor ligands and their complexes containing the MoO22+core

31 March 2024

8

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Liposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophages

31 March 2024

9

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Preparation of liposomes entrapping a high specific activity of 111In3+-bound inulin

31 March 2024

10

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies

31 March 2024

13

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases

31 March 2024

15

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Pharmacokinetics of targeting with liposomes

31 March 2024

16

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach

31 March 2024

21

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas--rationale for combination with radiotherapy

31 March 2024

23

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

(99m)Tc-labelled Stealth liposomal doxorubicin (Caelyx) in glioblastomas and metastatic brain tumours

31 March 2024

24

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient

31 March 2024

28

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients

31 March 2024

29

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Radio-frequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model

31 March 2024

30

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Synthesis and Characterization of Oxotechnetium(V) Mixed-Ligand Complexes Containing a Tridentate N-Substituted Bis(2-mercaptoethyl)amine and a Monodentate Thiol

31 March 2024

33

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Phase II Trial Of Pegylated-liposomal Doxorubicin (Doxil™) In Sarcoma*

31 March 2024

34

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Delivery of contrast agents for magnetic resonance imaging, computed tomography, nuclear medicine and ultrasound

31 March 2024

36

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia

31 March 2024

38

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

67Gallium-labeled liposomes with prolonged circulation: preparation and potential as nuclear imaging agents

31 March 2024

39

1 reference

https://api.crossref.org/works/10.1124/JPET.103.059535

31 March 2024

Identifiers

1 reference

5 December 2017

1 reference